Testing rectal cancer organ-preservation after radiation
Part of Cancer, Digestive system clinical trials.
This trial compares two ways to preserve the rectum/avoid major surgery after radiation: a focused contact x-ray treatment versus waiting longer and then removing only a small area if needed. It may help some people keep more normal bowel function while still controlling the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (over 18) with rectal cancer confirmed by biopsy
- Your cancer is located close to the anus (within 10 cm, above the dentate line)
- You previously had specific radiation treatment, and doctors are assessing how well it responded
- After treatment, you have either near-complete response or only a small remaining tumor (less than 3 cm)
- Both follow-up options must be possible for you: contact x-ray brachytherapy and local excision
- You cannot have had certain types of chemotherapy with/around the radiation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program that helps you and your doctor decide together whether to avoid surgery and keep your rectum after chemo and radiation. It's for people with early-stage rectal cancer who have not had prior treatment for this cancer.
This Phase 2 trial tests a “total neoadjuvant” treatment plan (medicine given before surgery) that may help some people avoid or reduce surgery for very low rectal cancer. It aims to improve the chance of keeping more normal function while still treating the cancer safely.
This trial studies whether combining chemotherapy and radiation can help people with early-stage rectal cancer keep their rectum and avoid surgery. It is for patients whose tumors have not spread to lymph nodes or other organs.
This study looks at how well people with rectal cancer do over time when they try to keep their rectum instead of having surgery. It is for patients who have already had chemoradiation and whose tumor has shrunk to a small scar (2 cm or less).
This trial tests a short course of radiation given before chemotherapy for people with locally advanced rectal cancer (cancer that has grown into nearby tissue and/or nearby lymph nodes but can still be removed). It may help shrink the tumor and make treatment more effective while assessing how well this approach works.
This Phase 2 study tests a “total neoadjuvant” (chemo plus radiation before the main treatment) plan to see if some people with low rectal cancer can keep their anus. It may help you avoid permanent colostomy if your cancer responds well and you meet the study rules.
Hear when a new Organ Preservation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.